A Florida resident alleges that Bayer Healthcare and Janssen Pharmaceuticals failed to warn patients and provide information to the medical community about the increased risks of gastrointestinal bleeding events associated with taking the blood thinning drug Xarelto.

According to the Xarelto lawsuit, plaintiff Helena M. used Xarelto beginning in April 2013 and she subsequently experienced gastrointestinal bleeding, for which she was hospitalized in December 2013.

The plaintiff also alleges other life-threatening severe and personal injuries that were a result of Bayer and Janssen’s failure to warn about Xarelto bleeding side effects.

Helena has filed her Xarelto lawsuit in the multidistrict litigation currently pending in the U.S. District Court for the Eastern District of Louisiana.

Xarelto Side Effects, Internal Bleeding

Xarelto (rivaroxaban) is one of the latest generation of anticoagulant drugs designed to treat patients at risk of deep vein thrombosis (the formation of blood clots deep under the skin surface).

Along with two similar medications (Pradaxa and Eliquis), Xarelto was intended to replace Warfarin, a blood thinner medication that has been the standard treatment for this condition since the early 1950s.

The advertised advantage of Xarelto and similar medications is that patients do not have to endure frequent monitoring and have less dietary restrictions; these prescriptions have far fewer drug and food interactions than Warfarin.

The most serious side effect associated with Xarelto is uncontrollable internal bleeding. Unlike other blood thinning drugs, there is no antidote for Xarelto.

This means that if a patient begins to bleed from Xarelto there is no way to reverse this until Xarelto is completely out of the body. This has resulted in a number of reported hospitalizations and deaths from Xarelto bleeding.

Xarelto Multidistrict Litigation

A multidistrict litigation was formed for the federally filed Xarelto lawsuits in December 2014. A motion was made to make this consolidation due to the large and growing number of cases filed in the federal court system against the manufacturers of Xarelto.

These lawsuits were able to be consolidated because they made similar allegations against the same defendants, the allegations being that Xarelto causes severe uncontrollable internal bleeding that can lead to serious injury and death in patients and that the manufacturers were aware of the dangers yet put the drug to market anyway. There are currently more than 1,200 cases in the MDL.

The Xarelto MDL has become one of the fastest growing mass torts concerning a product liability claim because the number of cases filed has significantly increased since the MDL was formed.

The purpose of an MDL is to expedite the litigation process for all parties involved, save on judicial resources, and speed up the pretrial litigation and discovery process.

Judge Eldon Fallon, the District Court judge who is presiding over the Xarelto multidistrict litigation, issued the order that scheduled the first four Xarelto bellwether trials.

The first trial will be held in the Eastern District of Louisiana on Feb. 6, 2017. The second trial will be held in the same district on Mar. 13, 2017.

For the third trial the venue will be moved to Mississippi and be held on Apr. 24, 2017. For the fourth trial, the venue will be moved to Texas and the trial will be held on May 30, 2017.

If you or a loved one have suffered injuries including uncontrollable gastrointestinal bleeding from taking Xarelto you may be entitled to compensation.

The Xarelto Bleeding Lawsuit is Case No. 2:15-cv-04421-EEF-MBN in the U.S. District Court for the Eastern District of Louisiana and the Xarelto MDL is In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL No. 2592 U.S. District Court, Eastern District of Louisiana.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Xarelto attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Xarelto class action lawsuit is best for you. [In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More

Get Help – It’s Free

Join a Free Xarelto Class Action Lawsuit Investigation

If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.

An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.

First Name*
Last Name*
Street Address*
Apt. #
City*
State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
Zip Code*
Phone*
Email*
Which blood thinner did you or a loved one take at the time of the injury or injuries?*
- Pradaxa
- Xarelto
- Unknown
- Other
Please check the injuries suffered:*
- Death
- Gastrointestinal Bleeding
- Other Internal Bleeding
- Cerebral Hemorrhaging
- Unsure
- None
¿Necesita un orador español?
- Yes
- No
Please enter any additional details you would like the staff reviewing your submission to know.*
I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
- Yes

if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 35) {gformInitChosenFields(‘#input_35_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_35_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_35_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [35, 1]) } );

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

Email*
State*
selectAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific

jQuery(document).ready(function($){gformInitSpinner( 5, ‘http://topclassactionscom.c.presscdn.com/wp-content/plugins/gravityforms/images/spinner.gif’ );jQuery(‘#gform_ajax_frame_5’).load( function(){var contents = jQuery(this).contents().find(‘*’).html();var is_postback = contents.indexOf(‘GF_AJAX_POSTBACK’) >= 0;if(!is_postback){return;}var form_content = jQuery(this).contents().find(‘#gform_wrapper_5’);var is_confirmation = jQuery(this).contents().find(‘#gform_confirmation_wrapper_5’).length > 0;var is_redirect = contents.indexOf(‘gformRedirect(){‘) >= 0;var is_form = form_content.length > 0 && ! is_redirect && ! is_confirmation;if(is_form){jQuery(‘#gform_wrapper_5’).html(form_content.html());setTimeout( function() { /* delay the scroll by 50 milliseconds to fix a bug in chrome */ jQuery(document).scrollTop(jQuery(‘#gform_wrapper_5’).offset().top); }, 50 );if(window[‘gformInitDatepicker’]) {gformInitDatepicker();}if(window[‘gformInitPriceFields’]) {gformInitPriceFields();}var current_page = jQuery(‘#gform_source_page_number_5’).val();gformInitSpinner( 5, ‘http://topclassactionscom.c.presscdn.com/wp-content/plugins/gravityforms/images/spinner.gif’ );jQuery(document).trigger(‘gform_page_loaded’, [5, current_page]);window[‘gf_submitting_5’] = false;}else if(!is_redirect){var confirmation_content = jQuery(this).contents().find(‘#gforms_confirmation_message_5’).html();if(!confirmation_content){confirmation_content = contents;}setTimeout(function(){jQuery(‘#gform_wrapper_5’).replaceWith(” + confirmation_content + ”);jQuery(document).scrollTop(jQuery(‘#gforms_confirmation_message_5’).offset().top);jQuery(document).trigger(‘gform_confirmation_loaded’, [5]);window[‘gf_submitting_5’] = false;}, 50);}else{jQuery(‘#gform_5’).append(contents);if(window[‘gformRedirect’]) {gformRedirect();}}jQuery(document).trigger(‘gform_post_render’, [5, current_page]);} );} ); if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 5) {gformInitChosenFields(‘#input_5_2′,’No results matched’);} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_5_2′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [5, 1]) } );

Top Class Actions is a Proud Member of the American Bar Association

american-bar-association